Earlier last month, NCCN announced a new oncologist tool for cost-benefit analysis. The announcement lacked concrete answers, but the reveal is quickly approaching.
National Comprehensive Cancer Network (NCCN) has been working on their value initiative tool for over 2 years. Their goal: To further empower patients to make treatment decisions in line with their values - with a deeper provider/patient discussion re: drugs, costs, outcomes, mortality, life span, etc. They will introduce the new infographic tool for evaluating treatment decisions at a press conference at the start of the NCCN 10th Annual Congress: Hematologic Malignancies.